First patients dosed in a Phase 1 study evaluating MES1022, a subcutaneous bone-selective EP4-agonist for bone regeneration $15M in funding raised to date to support clinical trial VANCOUVER, BC – Mesentech,… Read More
Vancouver, B.C., Toronto, ON – On September 30, LifeLabs will pause operations to recognize National Day for Truth and Reconciliation and Orange Shirt Day. This day honours the lost children and… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) welcomes the announcement of the federal government’s commitment to safeguarding the health of Canadians through the creation of Health Emergency Readiness Canada (HERC)…. Read More
The notified body, TÜV SÜD, reinstates Getinge’s CE certificate for HLS and PLS consumables, used for ECLS therapy, with certain conditions. Temporary challenges with a supplier and production changeover related… Read More
EUDRACAP® colon is the only functional, ready-to-fill capsule on the market targeting the ileo-colonic region New capsule is available in technical grade with a GMP product in development Further builds… Read More
